Li Zhou
Shanghai Jiao Tong University · 77 works · 3,924 citations · h-index 17
Top works
- Integrated digital error suppression for improved detection of circulating tumor DNA
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
- Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
- Role of KEAP1 / NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance
- (S012) Circulating Tumor DNA Detects Residual Disease and Anticipates Tumor Progression Earlier Than CT Imaging
- Noninvasive Detection of Ibrutinib Resistance in Non-Hodgkin Lymphoma Using Cell-Free DNA
- Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer
- Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst
- Long-Term Survival of a Patient With Non–Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene
- Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma
- Mutagenesis in mammalian cells can be modulated by radiation-induced voltage-dependent potassium channels
- Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma
- Prediction of therapeutic outcomes in DLBCL from circulating tumor DNA dynamics.
- Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
- Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non–Small-Cell Lung Cancer in the United States and Vietnam
- MA17.07 Circulating Tumor DNA Detects Minimal Residual Disease and Predicts Outcome in Localized Lung Cancer
- Analysis of Circulating Tumor DNA in Esophageal Carcinoma Patients Treated With Chemoradiation Therapy
- Circulating Tumor DNA as a Biomarker for Pancreatic Adenocarcinoma
- Noninvasive molecular subtyping and risk stratification of DLBCL.
- Integrated digital error suppression for noninvasive detection of circulating tumor DNA in NSCLC.